MediWound Ltd. (MDWD) vs Nkarta, Inc. (NKTX)
A side-by-side comparison of MediWound Ltd. and Nkarta, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDWD
MediWound Ltd.
$13.50HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
NKTX
Nkarta, Inc.
$2.42HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — MDWD vs NKTX
growth of $100 · dividends reinvested · last 6yMDWD -45.2% (-9.5%/yr)NKTX -94.7% (-38.7%/yr)MDWD compounded faster over this window
Log scale — wide-divergence pair
MDWD NKTX
MDWD vs NKTX: by the numbers
- •MDWD is the larger company ($173M vs $173M market cap).
- •Both run net losses; NKTX's is the smaller (0.00% vs -170.10% net margin).
Metrics side by side
Valuation
| Metric | MDWD | NKTX |
|---|---|---|
| P/S ratio | 14.62 | N/A |
| P/B ratio | 4.87 | 0.70 |
Profitability
| Metric | MDWD | NKTX |
|---|---|---|
| Gross margin | 15.46% | 0.00% |
| Operating margin | -149.06% | 0.00% |
| Net margin | -170.10% | 0.00% |
| ROE | -56.61% | -47.36% |
| ROIC | -58.55% | -42.11% |
Growth (annualized)
| Metric | MDWD | NKTX |
|---|---|---|
| Revenue CAGR (5Y) | -13.99% | N/A |
| Total return CAGR (5Y) | -9.04% | -37.28% |
Frequently asked
- How have MDWD and NKTX total returns compared?
- Over the past 5 years, MDWD delivered -9.04% and NKTX delivered -37.28% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.